ArticleEmerging infectious diseases2007
Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK.
Article in Emerging infectious diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.Antimicrobial agents and chemotherapy · 2013Pooled it
- Effects of Antibiotic Stewardship Program on Antibiotic Consumption and the Incidence ofAntibiotics (Basel, Switzerland) · 2026Article
- Systemic Absorption of Oral and Rectal Vancomycin in a Critically Ill Patient: A Case Report.Cureus · 2024Article
- Evaluation of anti-infective-relatedInternational journal of medical sciences · 2020Article
- Cationic Anthraquinone Analogs as Selective Antimicrobials.Microbiology insights · 2019Article
- Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review.Infectious diseases and therapy · 2016Review
- Article
- Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.Antibiotics (Basel, Switzerland) · 2015Review
- Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole.PloS one · 2014Article
- The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort study.PloS one · 2014Article
- Community-associated Clostridium difficile infections, Monroe County, New York, USA.Emerging infectious diseases · 2012Article
- Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Quebec, Canada.Antimicrobial agents and chemotherapy · 2012Article
- Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage.Journal of medical microbiology · 2012Article
- Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.BMC infectious diseases · 2011Article
- [Clostridium difficile-associated infections. How dangerous are the new strains?].Der Internist · 2010Article
- Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces.Journal of clinical microbiology · 2009Article
- [Nosocomial infections: MRSA und CDAD as a challenge].Der Internist · 2009Review
- Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.Clinical transplantationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In a population-based case-control study of community acquired Clostridium difficile-associated disease (CDAD), we matched 1,233 cases to 12,330 controls. CDAD risk increased 3-fold with use of any antimicrobial agent and 6-fold with use of fluoroquinolones. Prior use of antimicrobial agents did not affect risk for CDAD after 6 months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.